Search

Tho V. Duong

Examiner (ID: 6107, Phone: (571)272-4793 , Office: P/3744 )

Most Active Art Unit
3744
Art Unit(s)
3743, 3744, 3753, 3763
Total Applications
2124
Issued Applications
1350
Pending Applications
144
Abandoned Applications
669

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16175350 [patent_doc_number] => 20200222318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => CLOTTING FACTOR PREPARATIONS FOR DELIVERY INTO TISSUE OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE [patent_app_type] => utility [patent_app_number] => 16/790540 [patent_app_country] => US [patent_app_date] => 2020-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40422 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -50 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790540 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/790540
Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device Feb 12, 2020 Issued
Array ( [id] => 16086983 [patent_doc_number] => 20200197478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => USE OF ANTIMICOBIAL PEPTIDES FOR TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 16/790666 [patent_app_country] => US [patent_app_date] => 2020-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3530 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790666 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/790666
Use of antimicrobial peptides for treatment of cancer Feb 12, 2020 Issued
Array ( [id] => 16086985 [patent_doc_number] => 20200197479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => USE OF ANTIMICOBIAL PEPTIDES FOR TREATMENT OF INFECTION [patent_app_type] => utility [patent_app_number] => 16/790669 [patent_app_country] => US [patent_app_date] => 2020-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3534 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790669 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/790669
Use of antimicobial peptides for treatment of infection Feb 12, 2020 Issued
Array ( [id] => 17627259 [patent_doc_number] => 20220162274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => PRODUCTION AND USES OF ARTIFICAL HISTONE H1 FOR ANALYZING, DIAGNOSING, TREATING, AND/OR PREVENTING SENESCENCE [patent_app_type] => utility [patent_app_number] => 17/430241 [patent_app_country] => US [patent_app_date] => 2020-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8995 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430241 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/430241
PRODUCTION AND USES OF ARTIFICAL HISTONE H1 FOR ANALYZING, DIAGNOSING, TREATING, AND/OR PREVENTING SENESCENCE Feb 10, 2020 Abandoned
Array ( [id] => 16236831 [patent_doc_number] => 20200254065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => LONG-ACTING GLP-2 ANALOGS [patent_app_type] => utility [patent_app_number] => 16/787810 [patent_app_country] => US [patent_app_date] => 2020-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19151 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -60 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16787810 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/787810
LONG-ACTING GLP-2 ANALOGS Feb 10, 2020 Abandoned
Array ( [id] => 15993445 [patent_doc_number] => 20200172593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => INSULIN DERIVATIVES [patent_app_type] => utility [patent_app_number] => 16/784643 [patent_app_country] => US [patent_app_date] => 2020-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7082 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 296 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16784643 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/784643
INSULIN DERIVATIVES Feb 6, 2020 Abandoned
Array ( [id] => 17505147 [patent_doc_number] => 20220098249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => ANTIMICROBIAL NCR2 PEPTIDES [patent_app_type] => utility [patent_app_number] => 17/310582 [patent_app_country] => US [patent_app_date] => 2020-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33411 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -117 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310582 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/310582
ANTIMICROBIAL NCR2 PEPTIDES Feb 6, 2020 Pending
Array ( [id] => 17563416 [patent_doc_number] => 20220127565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => A Self-Assembling Short Amphiphilic Peptide And Related Methods And Uses [patent_app_type] => utility [patent_app_number] => 17/429132 [patent_app_country] => US [patent_app_date] => 2020-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12022 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429132 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/429132
A Self-Assembling Short Amphiphilic Peptide And Related Methods And Uses Feb 6, 2020 Abandoned
Array ( [id] => 16533316 [patent_doc_number] => 10875900 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-29 [patent_title] => Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells [patent_app_type] => utility [patent_app_number] => 16/782544 [patent_app_country] => US [patent_app_date] => 2020-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 6787 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782544 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/782544
Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells Feb 4, 2020 Issued
Array ( [id] => 17503495 [patent_doc_number] => 20220096597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => CARDIO-PROTECTIVE EFFECT OF VASOCONSTRICTION-INHIBITING FACTOR (VIF) [patent_app_type] => utility [patent_app_number] => 17/428508 [patent_app_country] => US [patent_app_date] => 2020-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8431 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428508 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/428508
CARDIO-PROTECTIVE EFFECT OF VASOCONSTRICTION-INHIBITING FACTOR (VIF) Feb 4, 2020 Abandoned
Array ( [id] => 17561736 [patent_doc_number] => 20220125885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => GLUCAGON ANALOG AGONISTS AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/427782 [patent_app_country] => US [patent_app_date] => 2020-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13085 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17427782 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/427782
GLUCAGON ANALOG AGONISTS AND METHODS OF USING THE SAME Jan 28, 2020 Abandoned
Array ( [id] => 15931051 [patent_doc_number] => 20200157159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => PEPTIDE COMPOUNDS AND COMPOSITIONS THEREOF [patent_app_type] => utility [patent_app_number] => 16/775877 [patent_app_country] => US [patent_app_date] => 2020-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27101 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16775877 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/775877
PEPTIDE COMPOUNDS AND COMPOSITIONS THEREOF Jan 28, 2020 Abandoned
Array ( [id] => 16206533 [patent_doc_number] => 20200239523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 16/774686 [patent_app_country] => US [patent_app_date] => 2020-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41460 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16774686 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/774686
NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS Jan 27, 2020 Abandoned
Array ( [id] => 17407155 [patent_doc_number] => 11248024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-15 [patent_title] => Noxa-derived, cell death-inducing peptide eMTD [patent_app_type] => utility [patent_app_number] => 16/774423 [patent_app_country] => US [patent_app_date] => 2020-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 6556 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16774423 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/774423
Noxa-derived, cell death-inducing peptide eMTD Jan 27, 2020 Issued
Array ( [id] => 17272994 [patent_doc_number] => 20210379192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => SKELETAL MUSCLE TARGETING MOIETIES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/300507 [patent_app_country] => US [patent_app_date] => 2020-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33190 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17300507 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/300507
SKELETAL MUSCLE TARGETING MOIETIES AND USES THEREOF Jan 26, 2020 Abandoned
Array ( [id] => 16341720 [patent_doc_number] => 20200306370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => AMINO ACID AND PEPTIDE CONJUGATES AND CONJUGATION PROCESS [patent_app_type] => utility [patent_app_number] => 16/773241 [patent_app_country] => US [patent_app_date] => 2020-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39512 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773241 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/773241
AMINO ACID AND PEPTIDE CONJUGATES AND CONJUGATION PROCESS Jan 26, 2020 Abandoned
Array ( [id] => 16190792 [patent_doc_number] => 20200231641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => METHODS AND COMPOSITIONS FOR VISUALIZING SUMO [patent_app_type] => utility [patent_app_number] => 16/744889 [patent_app_country] => US [patent_app_date] => 2020-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17166 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744889 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/744889
METHODS AND COMPOSITIONS FOR VISUALIZING SUMO Jan 15, 2020 Abandoned
16/742195 PEPTIDE, COMPOSITION AND METHOD FOR ANTI-HAIR GRAYING Jan 13, 2020 Abandoned
Array ( [id] => 16504860 [patent_doc_number] => 20200384116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-10 [patent_title] => SELF-ASSEMBLING VERTEPORFIN AMPHIPHILES (SAVA) FOR LOCAL CANCER THERAPY [patent_app_type] => utility [patent_app_number] => 16/739956 [patent_app_country] => US [patent_app_date] => 2020-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16739956 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/739956
SELF-ASSEMBLING VERTEPORFIN AMPHIPHILES (SAVA) FOR LOCAL CANCER THERAPY Jan 9, 2020 Abandoned
Array ( [id] => 18902705 [patent_doc_number] => 20240018190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => CONDUCTIVE SYNTHETIC PEPTIDES FOR MOLECULAR ELECTRONICS [patent_app_type] => utility [patent_app_number] => 17/373763 [patent_app_country] => US [patent_app_date] => 2020-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18116 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17373763 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/373763
CONDUCTIVE SYNTHETIC PEPTIDES FOR MOLECULAR ELECTRONICS Jan 9, 2020 Pending
Menu